Article

Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder.

Psychopharmacology (Impact Factor: 3.99). 06/2003; 167(2):219-20. DOI: 10.1007/s00213-003-1396-z
Source: PubMed
0 Followers
 · 
79 Views